Cullen Capital Management LLC Takes $3.97 Million Position in Cigna Group $CI

Cullen Capital Management LLC acquired a new position in shares of Cigna Group (NYSE:CI) in the second quarter, Holdings Channel.com reports. The fund acquired 14,417 shares of the health services provider’s stock, valued at approximately $3,974,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CI. Wilkerson Advisory Group LLC bought a new position in Cigna Group in the fourth quarter valued at $25,000. Osbon Capital Management LLC bought a new stake in Cigna Group during the second quarter worth about $26,000. Johnson Financial Group Inc. bought a new stake in Cigna Group during the second quarter worth about $29,000. Kemnay Advisory Services Inc. purchased a new position in shares of Cigna Group in the 4th quarter worth about $29,000. Finally, Prosperity Bancshares Inc bought a new position in shares of Cigna Group during the 4th quarter valued at about $29,000. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Cigna Group Stock Performance

NYSE:CI opened at $280.32 on Tuesday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47. The firm has a market cap of $74.07 billion, a PE ratio of 11.60, a price-to-earnings-growth ratio of 0.95 and a beta of 0.29. The business has a 50 day moving average price of $283.92 and a 200-day moving average price of $281.48.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. During the same period in the previous year, the firm earned $7.20 earnings per share. The firm’s revenue for the quarter was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities research analysts predict that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be given a $1.56 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s payout ratio is presently 25.82%.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on CI. Raymond James Financial cut Cigna Group from a “strong-buy” rating to an “outperform” rating and decreased their price objective for the company from $350.00 to $320.00 in a report on Monday, August 3rd. UBS Group upped their target price on Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a research note on Friday, May 22nd. Jefferies Financial Group downgraded shares of Cigna Group from a “buy” rating to a “hold” rating and decreased their price target for the stock from $336.00 to $307.00 in a research note on Tuesday, August 4th. Wall Street Zen cut shares of Cigna Group from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Finally, The Goldman Sachs Group increased their target price on shares of Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a report on Monday, May 4th. Fifteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $339.45.

Insider Activity

In related news, insider Nicole S. Jones sold 19,436 shares of the business’s stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the transaction, the insider owned 27,256 shares in the company, valued at $7,530,015.12. The trade was a 41.63% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. The trade was a 27.52% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 23,012 shares of company stock valued at $6,386,550. Insiders own 0.60% of the company’s stock.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.